Literature DB >> 4353930

Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine.

E R Kern, J C Overall, L A Glasgow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4353930     DOI: 10.1093/infdis/128.3.290

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  34 in total

1.  Pharmacokinetics of E-5-(2-bromovinyl)-2'-deoxyuridine in mice.

Authors:  E de Clercq; J Descamps; P de Somer; P J Barr; A S Jones; R T Walker
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

2.  Herpes genitalis in guinea-pigs. I. Kinetic study in infection with Herpesvirus hominis type 2.

Authors:  B Lukás; W Wiesendanger; K H Schmidt-Ruppin
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

3.  Genital herpesvirus hominis infection in mice. I. Development of an experimental model.

Authors:  J C Overall; E R Kern; R L Schlitzer; S B Friedman; L A Glasgow
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

4.  Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine.

Authors:  E R Kern; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

5.  Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex.

Authors:  E R Kern; G A Olsen; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

6.  Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid.

Authors:  E R Kern; J T Richards; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

7.  Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation.

Authors:  Sarah J Kopp; Andrew H Karaba; Laura K Cohen; Ghazal Banisadr; Richard J Miller; William J Muller
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

8.  Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.

Authors:  James R Beadle; Caroll Hartline; Kathy A Aldern; Natalie Rodriguez; Emma Harden; Earl R Kern; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Early and late pathologic changes in the adrenal glands of mice after infection with herpes simplex virus type 1.

Authors:  M Nachtigal; J B Caulfield
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

10.  Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.

Authors:  E de Clercq; Z X Zhang; I S Sim
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.